Shri Gomtesh Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.98 M
- Company Age 30 Year, 5 Months
- Last Filing with ROC 31 Mar 2003
- Open Charges ₹ 2.27 M
About Shri Gomtesh Bio-Tech
Shri Gomtesh Bio-Tech Private Limited (SGBPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 August 1994 and has a history of 30 years and five months. Its registered office is in Kolhapur, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2003. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.98 M.
The company currently has active open charges totaling ₹2.27 M.
Company Details
-
Location
Kolhapur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24119PN1994PTC080146
-
Company No.
080146
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Aug 1994
-
Date of AGM
29 Sep 2003
-
Date of Balance Sheet
31 Mar 2003
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Shri Gomtesh Bio-Tech?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Shri Gomtesh Bio-Tech.
Enhance accessibility to Shri Gomtesh Bio-Tech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shri Gomtesh Bio-Tech?
Unlock access to Shri Gomtesh Bio-Tech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹2.27 M
₹0
Charges Breakdown by Lending Institutions
- The United Western Bank Limited : 0.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2000 | The United Western Bank Limited | ₹0.60 M | Open |
| 12 Dec 2000 | The United Western Bank Limited | ₹0.85 M | Open |
| 29 Mar 1997 | The United Western Bank Limited | ₹0.82 M | Open |
How Many Employees Work at Shri Gomtesh Bio-Tech?
Unlock and access historical data on people associated with Shri Gomtesh Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shri Gomtesh Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shri Gomtesh Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.